Therapeutic Potential of Adult Progenitor Cells in the Management of Chronic Myocardial Ischemia

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.8, Iss.5, 2008-01, pp. : 315-326

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Approaches in Vascular Repair Induced by Adult Bone Marrow Cells and Circulating Progenitor Endothelial Cells

Current Pharmaceutical Design, Vol. 13, Iss. 31, 2007-11 ,pp. : 3245-3251

Bentham Science Publishers

Access to resources Recommend Favorite

Biodistributon and persistence of adult progenitor cells

Reproductive BioMedicine Online, Vol. 13, Iss. 1, 2006-07 ,pp. : 109-109

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Management of myocardial ischemia. Is ranolazine needed? For all or some patients with myocardial ischemia?

By Cocco Giuseppe

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 17, 2012-12 ,pp. : 2429-2432

Informa Healthcare

Access to resources Recommend Favorite

Vasopressin Receptor Antagonists: Therapeutic Potential in the Management of Acute and Chronic Heart Failure

By Russell S.D. DeWald T.

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 1, 2003-01 ,pp. : 13-20

Adis International

Access to resources Recommend Favorite

Cardiosphere-derived Progenitor Cells for Myocardial Repair Following Myocardial Infarction

Current Pharmaceutical Design, Vol. 20, Iss. 12, 2014-04 ,pp. : 2003-2011

Bentham Science Publishers

Access to resources Recommend Favorite